Cutoff Point Separating Affected and Unaffected Familial Hypercholesterolemic Patients Validated by LDL-receptor Gene MutantsHiroshi Mabuchi, 明広 稲津, Toshinori Higashikata et al.|Institutional Repositories DataBase (IRDB)|2005Cited by 0
Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.Masayuki Tsuchida, 正和 山岸, Masa‐aki Kawashiri et al.|Institutional Repositories DataBase (IRDB)|2009Cited by 0
The Relationship of Percent Body Fat by Bioelectrical Impedance Analysis with Blood Pressure, and Glucose and Lipid ParametersJunji Kobayashi, 宏 馬渕, Shunichi Murano et al.|Institutional Repositories DataBase (IRDB)|2006Cited by 0
Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.Hayato Tada, 研至 林, Masa‐aki Kawashiri et al.|Institutional Repositories DataBase (IRDB)|2016Cited by 0
Risk Evaluation of Coronary Heart Disease and Cerebrovascular Disease by the Japan Atherosclerosis Society Guidelines 2002 Using the Cohort of the Holicos-PAT StudyJunji Koizumi, 宏 馬渕, Tomio KAMETANI et al.|Institutional Repositories DataBase (IRDB)|2005Cited by 0